FDA Approves First Over-The-Counter Opioid Overdose Treatment
On Wednesday, the Food and Drug Administration approved an over-the-counter version of naloxone (opioid overdose reversal drug). This move is expected to increase access to lifesaving medication. Up until now, naloxone was available in the United States only as a prescription drug.
Dr. Scott Hadland, a pediatrician and an addiction specialist at MassGeneral Hospital for Children in Boston, said, "With its availability over the counter, this drug could save more lives."
The company informs that over-the-counter Narcan, which will be sold as a single-dose nasal spray, may become available in late summer, and it would be available in sites like convenience and grocery stores and even vending machines following the FDA approval. It will be packaged in a larger box with pictures and clear instructions to assist people in administering the drug more efficiently.
IJCP Editorial Team
Comprising seasoned professionals and experts from the medical field, the IJCP editorial team is dedicated to delivering timely and accurate content and thriving to provide attention-grabbing information for the readers. What sets them apart are their diverse expertise, spanning academia, research, and clinical practice, and their dedication to upholding the highest standards of quality and integrity. With a wealth of experience and a commitment to excellence, the IJCP editorial team strives to provide valuable perspectives, the latest trends, and in-depth analyses across various medical domains, all in a way that keeps you interested and engaged.
More FAQs by IJCP Editorial Team
Medtalks is India's fastest growing Healthcare Learning and Patient Education Platform designed and developed to help doctors and other medical professionals to cater educational and training needs and to discover, discuss and learn the latest and best practices across 100+ medical specialties. Also find India Healthcare Latest Health News & Updates on the India Healthcare at Medtalks
Please login to comment on this article